Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

European Commission approves Effentora for breakthrough cancer pain

April 16, 2008

Rituxan fails to meet primary endpoint in primary-progressive MS study

April 15, 2008

Z(Abeta3) binds to amyloid-beta(1-40), inhibits amyloid formation

April 15, 2008

Fatty acid amide hydrolase inhibitor ameliorates pain in preclinical study

April 15, 2008

ThromboGenics completes enrollment in phase II trial of microplasmin for acute stroke

April 15, 2008

Preclinical data supports use of AAV vectors to deliver siRNA

April 15, 2008

Mesoblast expands phase II spinal fusion trial and accelerates plans for phase III

April 15, 2008

Eisai refocuses E-2007 program

April 15, 2008

Abilify granted EU marketing authorization for manic episodes in bipolar I

April 14, 2008

Recombinant butyrylcholinesterase may play a neuroprotective role in AD

April 14, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...